Abstract
In Taiwan, breast cancer has been rapidly jumped to the first place in the incidence of women-specific malignancies. It will be urgent to discover some critical biomarkers predicting patient prognosis and outcome in Taiwan. Because Taiwanese breast cancer has a relatively lower incidence and earlier onset than Western population, the subset of clinical biomarkers and treatments applied in Western population may not be suitable for all Taiwanese population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
